Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Kenia Castro, M.D.
EIR
•Kenia Castro, M.D.•January 7, 2022

Kenia Castro, M.D. – FDA EIR, Jan 7, 2022

Record Details

An FDA inspection of Dr. Kenia Castro’s clinical research site in Hialeah, FL, was conducted from December 27, 2021, to January 7, 2022. This comprehensive "High Priority" inspection, carried out under Compliance Program 7348.811 for Clinical Investigators, evaluated Dr. Castro’s conduct in two drug efficacy studies.The inspection resulted in the issuance of a Form FDA 483, detailing two significant observations. Firstly, the investigation was not conducted in accordance with the investigational plan (21 CFR 312.60), as two subjects were improperly randomized into one study despite failing to meet critical inclusion or exclusion criteria. One subject was not on stable antipsychotic medication for the required 12 weeks, and another, taking a moderate enzyme inhibitor, was not genotyped as mandated by the protocol. This issue regarding inclusion/exclusion criteria was a repeat observation from a previous inspection in 2016. Secondly, the site failed to promptly report serious adverse effects to the sponsor, as required. Additional discussion points included a subject randomized with abnormal lab results and an adverse event not properly entered into the electronic data capture system.Dr. Castro acknowledged the findings, committing to a written response within 15 days and promising to implement stricter prescreening and more careful review of inclusion/exclusion criteria for all future studies. She also indicated staff changes related to trust in reviewing study details. The final classification of the inspection will be determined by the FDA's Center office, with a verbal warning issued regarding potential regulatory actions.

Company
Kenia Castro, M.D.
Inspection date
January 7, 2022
Product type
drugs
Office
Florida District Office
Person
  • Sheri L. Stephenson (issuing_officer)
View Company Profile

ID · bc26e328-3180-4fa9-8128-38d651e3765f

Violation Codes2
21 CFR 312.6021 CFR 312.64(b)

Full citation text and observation details available on the Dashboard.

Other documents for Kenia Castro, M.D.
  • 483 - 2022-01-07January 7, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kenia Castro, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.